Skip to Main Content

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.

And here is our regular feature in which we highlight a different person each week. This time around, we note that Enterprise Therapeutics named Dr. David Morris as chief medical officer. Previously, he worked at Novartis (NVS) Venture Fund, an investor in Enterprise, where he has been a managing director and where he will remain an operating partner.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!